{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T18:57:18Z","timestamp":1774119438444,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100018736","name":"Kaken Pharmaceutical","doi-asserted-by":"publisher","award":["23K19409"],"award-info":[{"award-number":["23K19409"]}],"id":[{"id":"10.13039\/100018736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018736","name":"Kaken Pharmaceutical","doi-asserted-by":"publisher","award":["23K11880"],"award-info":[{"award-number":["23K11880"]}],"id":[{"id":"10.13039\/100018736","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10072-026-08867-y","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:52:07Z","timestamp":1771393927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Midbrain length by the one-line method predicts motor outcome after deep brain stimulation in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9408-7893","authenticated-orcid":false,"given":"Hikaru","family":"Kamo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2009-2486","authenticated-orcid":false,"given":"Wataru","family":"Sako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genko","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akimitsu","family":"Suda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Iwamuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6808-0444","authenticated-orcid":false,"given":"Taku","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kamagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"issue":"9996","key":"8867_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/s0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386(9996):896\u2013912. https:\/\/doi.org\/10.1016\/s0140-6736(14)61393-3","journal-title":"Lancet"},{"issue":"10291","key":"8867_CR2","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/s0140-6736(21)00218-x","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397(10291):2284\u20132303. https:\/\/doi.org\/10.1016\/s0140-6736(21)00218-x","journal-title":"Lancet"},{"key":"8867_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2022.813387","volume":"16","author":"JK Wong","year":"2022","unstructured":"Wong JK et al (2022) Proceedings of the ninth annual Deep Brain Stimulation Think Tank: advances in cutting edge technologies, artificial intelligence, neuromodulation, neuroethics, pain, interventional psychiatry, epilepsy, and traumatic brain injury. Front Hum Neurosci 16:813387. https:\/\/doi.org\/10.3389\/fnhum.2022.813387","journal-title":"Front Hum Neurosci"},{"key":"8867_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.70411","author":"H Kamo","year":"2025","unstructured":"Kamo H et al (2025) Motor and cognitive outcome after subthalamic nucleus deep brain stimulation in patients with Parkinson\u2019s disease harboring GBA1 Variant (in eng). Mov Disord Clin Pract. https:\/\/doi.org\/10.1002\/mdc3.70411","journal-title":"Mov Disord Clin Pract"},{"key":"8867_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jdbs.2023.03.002","volume":"1","author":"A Umemura","year":"2023","unstructured":"Umemura A et al (2023) Application of current steering with MICC directional lead in STN-DBS for Parkinson\u2019s disease. Deep Brain Stimulation 1:20\u201325","journal-title":"Deep Brain Stimulation"},{"issue":"3","key":"8867_CR6","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1212\/wnl.0000000000012246","volume":"97","author":"F Bove","year":"2021","unstructured":"Bove F et al (2021) Long-term outcomes (15 years) after subthalamic nucleus deep brain stimulation in patients with Parkinson disease. Neurology 97(3):e254\u2013e262. https:\/\/doi.org\/10.1212\/wnl.0000000000012246","journal-title":"Neurology"},{"issue":"3","key":"8867_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/mdc3.13428","volume":"9","author":"H Kamo","year":"2022","unstructured":"Kamo H, Oyama G, Nishioka K, Funayama M, Hattori N (2022) Deep brain stimulation for a patient with familial Parkinson\u2019s disease harboring CHCHD2 p.T61I. Mov Disord Clin Pract 9(3):407\u2013409. https:\/\/doi.org\/10.1002\/mdc3.13428","journal-title":"Mov Disord Clin Pract"},{"key":"8867_CR8","doi-asserted-by":"publisher","unstructured":"Kamo OG, Shimizu H, Ito M, Iwamuro M, Umemura H, Hatano A (2026) Hattori TN Long-term mortality and 10-year outcomes after subthalamic nucleus deep brain stimulation in Parkinson\u2019s disease. Stereotact Funct Neurosurg 19:1-16. https:\/\/doi.org\/10.1159\/000550490","DOI":"10.1159\/000550490"},{"issue":"3","key":"8867_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/brain\/awf050","volume":"125","author":"ML Welter","year":"2002","unstructured":"Welter ML et al (2002) Clinical predictive factors of subthalamic stimulation in Parkinson\u2019s disease. Brain 125(3):575\u201383. https:\/\/doi.org\/10.1093\/brain\/awf050","journal-title":"Brain"},{"issue":"4","key":"8867_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jamaneurol.2013.6233","volume":"71","author":"MA Thenganatt","year":"2014","unstructured":"Thenganatt MA, Jankovic J (2014) Parkinson disease subtypes,. JAMA Neurol 71(4):499\u2013504. https:\/\/doi.org\/10.1001\/jamaneurol.2013.6233","journal-title":"JAMA Neurol"},{"key":"8867_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.70251","author":"H Kamo","year":"2025","unstructured":"Kamo H, Eisel MLS, Cagle JN, Johnson KA, Wong J, de Hemptinne C (2025) Finely tuned gamma oscillations in the globus pallidus internus in Parkinson\u2019s disease. Mov Disord Clin Pract. https:\/\/doi.org\/10.1002\/mdc3.70251","journal-title":"Mov Disord Clin Pract"},{"key":"8867_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1356042","volume":"15","author":"H Kamo","year":"2024","unstructured":"Kamo H, Oyama G, Yamasaki Y, Nagayama T, Nawashiro R, Hattori N (2024) A proof of concept: digital diary using 24-hour monitoring using wearable device for patients with Parkinson\u2019s disease in nursing homes. Front Neurol 15:1356042. https:\/\/doi.org\/10.3389\/fneur.2024.1356042","journal-title":"Front Neurol"},{"issue":"7","key":"8867_CR13","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/brain\/awx118","volume":"140","author":"SM Fereshtehnejad","year":"2017","unstructured":"Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB (2017) Clinical criteria for subtyping Parkinson\u2019s disease: biomarkers and longitudinal progression. Brain 140(7):1959\u20131976. https:\/\/doi.org\/10.1093\/brain\/awx118","journal-title":"Brain"},{"key":"8867_CR14","doi-asserted-by":"publisher","DOI":"10.1101\/2025.11.18.25340443","author":"GM Meyer","year":"2025","unstructured":"Meyer GM et al (2025) Deep brain stimulation and psychosis: A case series and two candidate causal brain circuits (in eng). MedRxiv. https:\/\/doi.org\/10.1101\/2025.11.18.25340443","journal-title":"MedRxiv"},{"issue":"8","key":"8867_CR15","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/mds.26701","volume":"31","author":"J Dams","year":"2016","unstructured":"Dams J, Dodel R (2016) An economic evaluation of deep brain stimulation for patients with Parkinson\u2019s disease. Mov Disord 31(8):1122\u20134. https:\/\/doi.org\/10.1002\/mds.26701","journal-title":"Mov Disord"},{"issue":"12","key":"8867_CR16","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u2013601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"4","key":"8867_CR17","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/1531-8257(199907)14:4<572::aid-mds1005>3.0.co;2-c","volume":"14","author":"GL Defer","year":"1999","unstructured":"Defer GL, Widner H, Mari\u00e9 RM, R\u00e9my P, Levivier M (1999) Core assessment program for surgical interventional therapies in Parkinson\u2019s disease (CAPSIT-PD). Mov Disord 14(4):572\u201384. https:\/\/doi.org\/10.1002\/1531-8257(199907)14:4%3C;572::aid-mds1005%3E;3.0.co;2-c","journal-title":"Mov Disord"},{"issue":"15","key":"8867_CR18","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG et al (2008) Movement disorder society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23(15):2129\u201370. https:\/\/doi.org\/10.1002\/mds.22340","journal-title":"Mov Disord"},{"issue":"2","key":"8867_CR19","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","volume":"62","author":"B Fischl","year":"2012","unstructured":"Fischl B (2012) FreeSurfer. Neuroimage 62(2):774\u201381. https:\/\/doi.org\/10.1016\/j.neuroimage.2012.01.021","journal-title":"Neuroimage"},{"issue":"3","key":"8867_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/ane.13136","volume":"140","author":"W Sako","year":"2019","unstructured":"Sako W et al (2019) One line: A method for differential diagnosis of parkinsonian syndromes (in eng). Acta Neurol Scand 140(3):229\u2013235. https:\/\/doi.org\/10.1111\/ane.13136","journal-title":"Acta Neurol Scand"},{"issue":"10","key":"8867_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-016-0690-1","volume":"16","author":"A Nassery","year":"2016","unstructured":"Nassery A, Palmese CA, Sarva H, Groves M, Miravite J, Kopell BH (2016) Psychiatric and cognitive effects of deep brain stimulation for Parkinson\u2019s disease. Curr Neurol Neurosci Rep 16(10):87. https:\/\/doi.org\/10.1007\/s11910-016-0690-1","journal-title":"Curr Neurol Neurosci Rep"},{"key":"8867_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ana.25994","volume":"89","author":"F Cavallieri","year":"2021","unstructured":"Cavallieri F et al (2021) Predictors of long-term outcome of subthalamic stimulation in Parkinson disease. Ann Neurol 89:587\u2013597. https:\/\/doi.org\/10.1002\/ana.25994","journal-title":"Ann Neurol"},{"key":"8867_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2023.120821","volume":"454","author":"W Sako","year":"2023","unstructured":"Sako W et al (2023) Midbrain atrophy in pathologically diagnosed Lewy body disease and clinically diagnosed Parkinson\u2019s disease. J Neurol Sci 454:120821. https:\/\/doi.org\/10.1016\/j.jns.2023.120821","journal-title":"J Neurol Sci"},{"issue":"3","key":"8867_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab191","volume":"3","author":"CR Eickhoff","year":"2021","unstructured":"Eickhoff CR et al (2021) Advanced brain ageing in Parkinson\u2019s disease is related to disease duration and individual impairment. Brain Commun 3(3):fcab191. https:\/\/doi.org\/10.1093\/braincomms\/fcab191","journal-title":"Brain Commun"},{"key":"8867_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01494","volume":"10","author":"NE Chambers","year":"2019","unstructured":"Chambers NE, Lanza K, Bishop C (2019) Pedunculopontine nucleus degeneration contributes to both motor and non-motor symptoms of Parkinson\u2019s disease. Front Pharmacol 10:1494. https:\/\/doi.org\/10.3389\/fphar.2019.01494","journal-title":"Front Pharmacol"},{"issue":"Pt 8","key":"8867_CR26","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","volume":"136","author":"JH Kordower","year":"2013","unstructured":"Kordower JH et al (2013) Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease. Brain 136(Pt 8):2419\u201331. https:\/\/doi.org\/10.1093\/brain\/awt192","journal-title":"Brain"},{"issue":"2","key":"8867_CR27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3233\/jpd-191890","volume":"10","author":"KL Poston","year":"2020","unstructured":"Poston KL et al (2020) Substantia nigra volume dissociates bradykinesia and rigidity from tremor in Parkinson\u2019s disease: a 7 Tesla imaging study. J Parkinsons Dis 10(2):591\u2013604. https:\/\/doi.org\/10.3233\/jpd-191890","journal-title":"J Parkinsons Dis"},{"issue":"9","key":"8867_CR28","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/mds.27365","volume":"33","author":"D Taniguchi","year":"2018","unstructured":"Taniguchi D et al (2018) Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson\u2019s disease. Mov Disord 33(9):1488\u20131492. https:\/\/doi.org\/10.1002\/mds.27365","journal-title":"Mov Disord"},{"key":"8867_CR29","doi-asserted-by":"publisher","unstructured":"JostST (2024) Neurostimulation for advanced parkinson disease and quality of life at 5 years: A nonrandomized controlled trial (in eng). JAMA Netw Open 7(1):e2352177. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.52177","DOI":"10.1001\/jamanetworkopen.2023.52177"},{"issue":"2","key":"8867_CR30","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/mdc3.13379","volume":"9","author":"Z Lin","year":"2022","unstructured":"Lin Z, Zhang C, Li D, Sun B (2022) Preoperative levodopa response and deep brain stimulation effects on motor outcomes in parkinson\u2019s disease: a systematic review (in eng). Mov Disord Clin Pract 9(2):140\u2013155 https:\/\/doi.org\/10.1002\/mdc3.13379","journal-title":"Mov Disord Clin Pract"},{"key":"8867_CR31","doi-asserted-by":"publisher","unstructured":"Artusi CA, Lopiano L, Morgante F (2024) Deep brain stimulation selection criteria for Parkinson\u2019s disease: Time to Go beyond CAPSIT-PD (in eng). J Clin Med 9(12) https:\/\/doi.org\/10.3390\/jcm9123931","DOI":"10.3390\/jcm9123931"},{"issue":"14","key":"8867_CR32","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1002\/mds.23294","volume":"25","author":"A Zaidel","year":"2010","unstructured":"Zaidel A, Bergman H, Ritov Y, Israel Z (2010) Levodopa and subthalamic deep brain stimulation responses are not congruent. Mov Disord 25(14):2379\u201386. https:\/\/doi.org\/10.1002\/mds.23294","journal-title":"Mov Disord"},{"issue":"6","key":"8867_CR33","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: a review. JAMA 323(6):548\u2013560. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"JAMA"},{"issue":"3","key":"8867_CR34","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3171\/2018.4.jns171909","volume":"131","author":"JA Hanna","year":"2018","unstructured":"Hanna JA et al (2018) Comparison of elderly and young patient populations treated with deep brain stimulation for Parkinson\u2019s disease: long-term outcomes with up to 7 years of follow-up (in eng). J Neurosurg 131(3):807\u2013812. https:\/\/doi.org\/10.3171\/2018.4.jns171909","journal-title":"J Neurosurg"},{"issue":"2","key":"8867_CR35","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/ner.13523","volume":"26","author":"SF Lange","year":"2023","unstructured":"Lange SF et al (2023) The intraoperative microlesion effect positively correlates with the short-term clinical effect of deep brain stimulation in Parkinson\u2019s disease. Neuromodulation 26(2):459\u2013465. https:\/\/doi.org\/10.1111\/ner.13523","journal-title":"Neuromodulation"},{"key":"8867_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/mds.70042","author":"MGJ de Neeling","year":"2025","unstructured":"de Neeling MGJ et al (2025) Temporal dynamics of beta power related to the stun effect in Parkinson\u2019s disease patients after deep brain stimulation Surgery (in eng). Mov Disord. https:\/\/doi.org\/10.1002\/mds.70042","journal-title":"Mov Disord"},{"key":"8867_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113926","volume":"348","author":"S Knorr","year":"2022","unstructured":"Knorr S et al (2022) Experimental deep brain stimulation in rodent models of movement disorders. Exp Neurol 348:113926. https:\/\/doi.org\/10.1016\/j.expneurol.2021.113926","journal-title":"Exp Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-08867-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-08867-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-08867-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T18:02:00Z","timestamp":1774116120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-08867-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["8867"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-08867-y","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Juntendo University Ethics Committee (approval number, M08-0477). Written informed consent was obtained from all patients who consented to participate in the study. This research study was conducted retrospectively from data obtained for clinical purposes. We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"HK received speaker honoraria from AbbVie, Inc. and grant support from the Japan Society for the Promotion of Science KAKENHI, and the Japanese Society of Neurology. WS received speaker honoraria from Sumitomo Pharma Co. Ltd., Ono Pharmaceutical Co. Ltd., Eisai Co. Ltd., Takeda Pharmaceutical Company Ltd., Kyowa Kirin Co. Ltd., and AbbVie, Inc. and received research support from Mitsubishi Tanabe Pharma Co. and JSPS KAKENHI. GO received speaker honoraria from Medtronic Inc., Boston Scientific, Abbott Japan LLC, Otsuka Pharmaceutical Co. Ltd., Sumitomo Pharma Co. Ltd., Eisai Co. Ltd., Takeda Pharmaceutical Company Ltd., Kyowa Kirin Co. Ltd., and AbbVie, Inc. HI received support as the person in charge of accepting endowed departments from Medtronic Inc., Boston Scientific Co., Kyowa Kirin Co. Ltd, Nippon Boehringer Ingelheim, Co. Ltd, and AbbVie, Inc. AU received support as the person in charge of accepting endowed departments from Medtronic Inc, Boston Scientific Co., Kyowa Kirin Co. Ltd, Nippon Boehringer Ingelheim, Co. Ltd, and AbbVie, Inc. TH received support as the person in charge of accepting endowed departments from Medtronic Inc., Boston Scientific Co., Kyowa Kirin Co. Ltd, Nippon Boehringer Ingelheim, Co. Ltd, and AbbVie, Inc. NH received support as the person in charge of accepting endowed departments from Medtronic Inc., Boston Scientific Co., Kyowa Kirin Co. Ltd, Nippon Boehringer Ingelheim, Co. Ltd, and AbbVie, Inc. The funding company did not influence data interpretation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial Disclosures for the previous 12 months"}},{"value":"The authors declare that there are no conflicts of interest relevant to this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"271"}}